Browsing by Author Kweon, YO

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 1 to 10 of 10
TitleAuthor(s)Issue DateViews
 
A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis
Journal:Journal of Hepatology
Mak, LYGane, ESchwabe, CYoon, KTHeo, JScott, RLee, JHLee, JIKweon, YOWeltman, MHarrison, SANeuschwander-Tetri, BACusi, KLoomba, RGiven, BDChristianson, DRGarcia-Medel, EYi, MHamilton, JYuen, RMF
2022
 
ARO-HSD reduces hepatic HSD17B13 mRNA expression and protein levels in patients with suspected NASH
Proceeding/Conference:Journal of Hepatology
Gane, ESchwabe, CYoon, KTHeo, JScott, RLee, JLee, JILKweon, YOWeltman, MHarrison, STetri, BCusi, KLoomba, RChristianson, DRajicic, NMartin, JSHamilton, JYuen, RMF
2021
39
 
Hepatitis B virus (HBV) surface antigen (HBsAg) inhibition with isis 505358 in chronic hepatitis B (CHB) patients on stable nucleos(t)ide analogue (NA)-naïve CHB patients: phase 2a, randomized, double-blind, placebo-controlled study.
Proceeding/Conference:Journal of Hepatology
Yuen, RMFHeo, JJang, JWYoon, J-HKweon, YOPark, S-JBennett, FKwoh, J
2020
120
 
Phase 2a, randomized, double-blind, placebo-controlled study of an antisense inhibitor (ISIS 505358) in treatment-naïve chronic hepatitis B (CHB) patients: safety and antiviral efficacy
Proceeding/Conference:Hepatology
Yuen, RMFHeo, JJang, JWYoon, JHKweon, YOPark, SJBennett, CFKwoh, TJ
2019
48
 
Phase IIb multicentred randomised trial of besifovir (LB80380) versus entecavir in Asian patients with chronic hepatitis B
Journal:Gut
Lai, CLAhn, SHLee, KSUm, SHCho, MYoon, SKLee, JWPark, NHKweon, YOSohn, JHLee, JKim, JAHan, KHYuen, RMF
2013
133
 
Results after 12 weeks treatment of multiple doses of GSK3389404 in chronic hepatitis B (CHB) subjects on stable nucleos(t)ide therapy in a phase 2a double-blind, placebo-controlled study
Proceeding/Conference:Hepatology
Yuen, RMFHeo, JKumada, HSuzuki, FSuzuki, YXie, QJia, JDKarino, YHou, JLChayama, KImamura, Mlao-Tan, JYLim, SGTanaka, YXie, WYoon, JHDuan, ZPKurosaki, MPark, SJLabio, EKumar, RKweon, YOYim, HJCremer, JElston, RChen, SGDavies, MBaptiste-Brown, SHan, KCampbell, FPaff, MTheodore, D
2019
105
 
Telbivudine combination with adefovir versus adefovir monotherapy in HBeAg-positive chronic hepatitis B (CHB) patients with lamivudine resistance
Proceeding/Conference:Hepatology International
Ahn, SHKweon, YOPaik, SWSohn, JHLee, KSKim, DJPiratvisuth, TYuen, RMFTrylesinski, AAvila, C
2010
57
 
Telbivudine in combination with adefovir versus adefovir monotherapy in HBeAg-positive, lamivudine-resistant chronic hepatitis B
Journal:Hepatology International
Ahn, SHKweon, YOPaik, SWSohn, JHLee, KSKim, DJPiratvisuth, TYuen, MFChutaputti, AChao, YCTrylesinski, AAvila, C
2012
166
 
Two-year treatment outcome of chronic hepatitis B infection treated with besifovir vs. entecavir: Results from a multicentre study
Journal:Journal of Hepatology
Yuen, RMFAhn, SHLee, KSUm, SHCho, MYoon, SKLee, JWPark, NHKweon, YOSohn, JHLee, JKim, JALai, CLHan, KH
2015
 
Week 48 analysis of a Phase IIB study of the efficacy and safety of LB80380 vs. entecavir in treatment-naive patients with chronic Hepatitis B
Proceeding/Conference:Hepatology
Lai, CLAhh, SHLee, KSUm, SHCho, MYoon, SKLee, JWPark, NHKweon, YOSohn, JHLee, JKim, JAHan, KHYuen, MF
2011
44
Showing results 1 to 10 of 10